An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study
- 31 August 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (2) , 368-374
- https://doi.org/10.1016/j.ygyno.2004.05.033
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Age-specific differences in treatment and survival of ovarian cancer patients in the province of Limburg, the Netherlands, 1986-92International Journal of Gynecologic Cancer, 1998
- Transvaginal Sonography as a Screening Method for the Detection of Early Ovarian CancerGynecologic Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- National survey of ovarian carcinoma IV: Patterns of care and related survival for older patientsCancer, 1994
- Impact of Age on Survival of Patients with Ovarian CancerGynecologic Oncology, 1993
- Age contrasts in patients with advanced epithelial ovarian cancer: The M. D. Anderson cancer center experienceCancer, 1993
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group studyCancer, 1986
- Ovarian cancer in the elderly: An analysis of Surveillance, Epidemiology, and End Results Program dataAmerican Journal of Obstetrics and Gynecology, 1986
- Prognostic significance of histologic classification and grading of epithelial malignancies of the ovaryAmerican Journal of Obstetrics and Gynecology, 1984